Have a feature idea you'd love to see implemented?
Let us know!
XOMA XOMA Corp
Price (delayed)
$28.46
Market cap
$333.11M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.45
Enterprise value
$311.13M
XOMA has built a significant portfolio of products that are licensed to and being developed by other biotechnology and pharmaceutical companies. The Company's portfolio of partner-funded programs spans multiple stages
Highlights
The revenue has soared by 162% from the previous quarter
XOMA's gross profit has soared by 162% from the previous quarter
The company's quick ratio has surged by 69% YoY but it fell by 11% QoQ
The company's equity rose by 21% QoQ but it fell by 9% YoY
Key stats
What are the main financial stats of XOMA
Market
Valuations
Earnings
Shares outstanding
11.7M
Market cap
$333.11M
Enterprise value
$311.13M
Price to book (P/B)
3.31
Price to sales (P/S)
21.74
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
20.42
Revenue
$15.24M
EBIT
-$10.71M
EBITDA
-$10.2M
Free cash flow
-$17.52M
Per share
Balance sheet
Liquidity
EPS
-$2.45
Free cash flow per share
-$1.51
Book value per share
$8.59
Revenue per share
$1.31
TBVPS
$20.9
Total assets
$243.28M
Total liabilities
$143.29M
Debt
$121.92M
Equity
$99.99M
Working capital
$143.59M
Debt to equity
1.22
Current ratio
8.71
Quick ratio
7.8
Net debt/EBITDA
2.15
Margins
Efficiency
Dividend
EBITDA margin
-66.9%
Gross margin
100%
Net margin
-119.6%
Operating margin
-280.9%
Return on assets
-10.9%
Return on equity
-23.7%
Return on invested capital
-6.7%
Return on capital employed
-4.8%
Return on sales
-70.3%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
XOMA stock price
How has the XOMA stock price performed over time
Intraday
-3.2%
1 week
0.81%
1 month
0.96%
1 year
66.92%
YTD
53.84%
QTD
7.48%
Financial performance
How have XOMA's revenue and profit performed over time
Revenue
$15.24M
Gross profit
$15.24M
Operating income
-$42.8M
Net income
-$18.23M
Gross margin
100%
Net margin
-119.6%
The revenue has soared by 162% from the previous quarter
XOMA's gross profit has soared by 162% from the previous quarter
The net margin has surged by 82% since the previous quarter and by 81% year-on-year
The operating income has plunged by 60% YoY and by 11% from the previous quarter
Growth
What is XOMA's growth rate over time
Valuation
What is XOMA stock price valuation
P/E
N/A
P/B
3.31
P/S
21.74
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
20.42
The EPS has grown by 38% from the previous quarter and by 9% YoY
XOMA's price to book (P/B) is 32% more than its last 4 quarters average of 2.5 and 3.4% more than its 5-year quarterly average of 3.2
The company's equity rose by 21% QoQ but it fell by 9% YoY
The revenue has soared by 162% from the previous quarter
The stock's P/S is 41% below its last 4 quarters average of 36.8 and 22% below its 5-year quarterly average of 28.0
Efficiency
How efficient is XOMA business performance
The ROS has soared by 89% YoY and by 88% from the previous quarter
The company's return on invested capital has surged by 83% YoY and by 76% QoQ
The return on assets has surged by 56% since the previous quarter and by 50% year-on-year
XOMA's ROE has increased by 48% from the previous quarter and by 3.7% YoY
Dividends
What is XOMA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for XOMA.
Financial health
How did XOMA financials performed over time
XOMA's total assets is 70% greater than its total liabilities
XOMA's total assets has surged by 94% year-on-year and by 11% since the previous quarter
The company's quick ratio has surged by 69% YoY but it fell by 11% QoQ
The debt is 22% greater than the equity
The company's equity rose by 21% QoQ but it fell by 9% YoY
The company's debt to equity fell by 17% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.